成年人中诊断患有前期糖尿病或糖尿病与未诊断患有前期糖尿病或糖尿病者之间使用远程医疗的情况，美国，2021 年和 2022 年。国家健康访谈调查。
Telemedicine Use Among Adults With and Without Diagnosed Prediabetes or Diabetes, National Health Interview Survey, United States, 2021 and 2022.
机构信息
Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA 30341 (
Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
出版信息
Prev Chronic Dis. 2024 Nov 14;21:E90. doi: 10.5888/pcd21.240229.
We analyzed 2021 and 2022 National Health Interview Survey data to describe the prevalence of past 12-month telemedicine use among US adults with no prediabetes or diabetes diagnosis, diagnosed prediabetes, and diagnosed diabetes. In 2021 and 2022, telemedicine use prevalence was 34.1% and 28.2% among adults without diagnosed diabetes or prediabetes, 47.6% and 37.6% among adults with prediabetes, and 52.8% and 39.4% among adults with diabetes, respectively. Differences in telemedicine use were identified by region, urbanicity, insurance status, and education among adults with prediabetes or diabetes. Findings suggest that telemedicine use can be improved among select populations with prediabetes or diabetes.
我们分析了 2021 年和 2022 年全国健康访谈调查数据，以描述美国无糖尿病或前期糖尿病诊断、确诊前期糖尿病和确诊糖尿病的成年人过去 12 个月使用远程医疗的情况。2021 年和 2022 年，无诊断糖尿病或前期糖尿病的成年人中远程医疗使用率分别为 34.1%和 28.2%，前期糖尿病患者中分别为 47.6%和 37.6%，糖尿病患者中分别为 52.8%和 39.4%。在有前期糖尿病或糖尿病的成年人中，远程医疗的使用存在区域、城市状况、保险状况和教育程度的差异。研究结果表明，可在有前期糖尿病或糖尿病的特定人群中提高远程医疗的使用。
Zotero 插件